These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
24 results:

  • 1. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.
    Dai X; Chen W; Qiao Y; Chen X; Chen Y; Zhang K; Zhang Q; Duan X; Li X; Zhao J; Tian F; Liu K; Dong Z; Lu J
    Cancer Lett; 2024 Feb; 582():216596. PubMed ID: 38101610
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Usefulness of Elastin Staining to Detect Vascular Invasion in cancer.
    Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IκB kinase-α coordinates brd4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.
    Pecharromán I; Solé L; Álvarez-Villanueva D; Lobo-Jarne T; Alonso-Marañón J; Bertran J; Guillén Y; Montoto Á; Martínez-Iniesta M; García-Hernández V; Giménez G; Salazar R; Santos C; Garrido M; Borràs E; Sabidó E; Bonfill-Teixidor E; Iurlaro R; Seoane J; Villanueva A; Iglesias M; Bigas A; Espinosa L
    EMBO J; 2023 Nov; 42(21):e114719. PubMed ID: 37737566
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Relevance of shrinkage versus fragmented response patterns in rectal cancer.
    Kus Ozturk S; Graham Martinez C; Sheahan K; Winter DC; Aherne S; Ryan ÉJ; van de Velde CJ; Marijnen CA; Hospers GA; Roodvoets AG; Doukas M; Mens D; Verhoef C; van der Post RS; Nagtegaal ID
    Histopathology; 2023 Dec; 83(6):870-879. PubMed ID: 37609761
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Utility of circulating tumour DNA for prognosis and prediction of therapeutic effect in locally recurrent rectal cancer: study protocol for a multi-institutional, prospective observational study (JCOG1801A1, cap-LR study).
    Hashimoto T; Tsukada Y; Ito M; Kanato K; Mizusawa J; Fukuda H; Tsukamoto S; Takashima A; Kanemitsu Y
    BMJ Open; 2023 Aug; 13(8):e073217. PubMed ID: 37586869
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genotype-Phenotype Correlations in Autosomal Dominant and Recessive APC Mutation-Negative colorectal Adenomatous Polyposis.
    Zhu LH; Dong J; Li WL; Kou ZY; Yang J
    Dig Dis Sci; 2023 Jul; 68(7):2799-2810. PubMed ID: 36862359
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KLF16 enhances stress tolerance of colorectal carcinomas by modulating nucleolar homeostasis and translational reprogramming.
    Ma XD; Xu SD; Hao SH; Han K; Chen JW; Ling H; Chen RX; Jin XH; Cao JH; Lin JL; Ou QJ; Fang YJ; Pan ZZ; Xie D; Wang FW
    Mol Ther; 2022 Aug; 30(8):2828-2843. PubMed ID: 35524408
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A new magnetic resonance imaging tumour response grading scheme for locally advanced rectal cancer.
    Pang X; Xie P; Yu L; Chen H; Zheng J; Meng X; Wan X
    Br J Cancer; 2022 Jul; 127(2):268-277. PubMed ID: 35388140
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
    Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
    Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Role of Fecal
    Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
    Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is There an Optimal Definition for a Positive Circumferential Resection Margin in Locally Advanced Esophageal cancer?
    Brac B; Dufour C; Behal H; Vanderbeken M; Labreuche J; Leteurtre E; Mariette C; Eveno C; Piessen G; Renaud F;
    Ann Surg Oncol; 2021 Dec; 28(13):8337-8346. PubMed ID: 34514523
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aberrantly Methylated and Expressed Genes as Prognostic Epigenetic Biomarkers for Colon cancer.
    Wu Y; Wan X; Jia G; Xu Z; Tao Y; Song Z; Du T
    DNA Cell Biol; 2020 Nov; 39(11):1961-1969. PubMed ID: 33085517
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Circular RNA is a popular molecule in tumors of the digestive system (Review).
    Wang HY; Wang YP; Zeng X; Zheng Y; Guo QH; Ji R; Zhou YN
    Int J Oncol; 2020 Jul; 57(1):21-42. PubMed ID: 32377736
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Fundamental control of grade-specific colorectal cancer morphology by Src regulation of ezrin-centrosome engagement.
    Rainey L; Deevi RK; McClements J; Khawaja H; Watson CJ; Roudier M; Van Schaeybroeck S; Campbell FC
    J Pathol; 2020 Jul; 251(3):310-322. PubMed ID: 32315081
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
    Guo CM; Liu SQ; Sun MZ
    Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. brd4 promotes tumor progression and NF-κB/CCL2-dependent tumor-associated macrophage recruitment in GIST.
    Mu J; Sun P; Ma Z; Sun P
    Cell Death Dis; 2019 Dec; 10(12):935. PubMed ID: 31819043
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic Factors for colorectal cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.
    Takimoto R; Kamigaki T; Okada S; Matsuda E; Ibe H; Oguma E; Naitoh K; Makita K; Goto S
    Anticancer Res; 2019 Aug; 39(8):4525-4532. PubMed ID: 31366555
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.
    Huijbers A; van Pelt GW; Kerr RS; Johnstone EC; Tollenaar RAEM; Kerr DJ; Mesker WE
    J Surg Oncol; 2018 Apr; 117(5):1043-1048. PubMed ID: 29448309
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.
    Goey KKH; Elias SG; van Tinteren H; Laclé MM; Willems SM; Offerhaus GJA; de Leng WWJ; Strengman E; Ten Tije AJ; Creemers GM; van der Velden A; de Jongh FE; Erdkamp FLG; Tanis BC; Punt CJA; Koopman M
    Ann Oncol; 2017 Sep; 28(9):2128-2134. PubMed ID: 28911067
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Missing Elements in Surgical Pathology Reports: Breast, Colon and Stomach cancers.
    Kadivar M; Rahimabad PK
    Asian Pac J Cancer Prev; 2016; 17(3):1469-72. PubMed ID: 27039791
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.